Loading...
Restrictive Reimbursement Will Undermine Ophthalmic Margins While Slow Recovery Emerges
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
54.1%7D
30.9%1Y
54.1%7D
30.9%You can edit this narrative until Aug 13 10:16 PM. Then, changes will post as Updates.